1

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

byppbnj2qtzs
Adoptive transfer of chimeric antigen receptor-transduced T cells is a promising strategy for cancer immunotherapy. The CD38 molecule. with its high expression on multiple myeloma cells. appears a suitable target for antibody therapy. https://unionlosangelers.shop/product-category/boots/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story